Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

MyAsthma

- PMLiVE

GSK’s COPD drug Anoro under review in US

FDA accepts new drug application for the LAMA/LABA combination

- PMLiVE

OncoAssist becomes latest app to be classified as a medical device

Cancer iPhone and iPad app offers clinical decision support tools

- PMLiVE

GSK signs obesity research deal with Vanderbilt University

Follows increased push from pharma to tackle the public health challenge

EU flag

Five pharma companies begin antibiotic research programme

Sanofi, GSK and AstraZeneca among the collaborators on European projects

- PMLiVE

GSK planning restructuring in Europe as earnings fall

Includes job cuts and potential sale of Ribena/Lucozade brands

- PMLiVE

Sanofi backs SMS chemotherapy compliance programme

Prost8Care delivers timed text message encouragement to cancer patients

- PMLiVE

GSK signs up to AllTrials trial transparency campaign

Will publish formal clinical study reports for all of its medicines

- PMLiVE

Boehringer launches COPD patient consultation app for HCPs

Extends reach of the calculator tools on its COPD Exchange website

- PMLiVE

GSK forms Indian vaccine research joint venture

Will work with local firm Biological E on six-in-one combination vaccine

- PMLiVE

GSK appoints Heineken and Shell director Hans Wijers to board

Is also chair designate of the brewery firm

Melanoma smartphone app claims ‘highly variable’

Applications that assess skin cancer risk often misclassify lesions

- PMLiVE

GSK and Theravance file COPD combo for EU approval

Filing for LAMA/LABA combination comes shortly after US submission

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links